BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 21122030)

  • 1. Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension.
    Boutou AK; Pitsiou GG; Trigonis I; Papakosta D; Kontou PK; Chavouzis N; Nakou C; Argyropoulou P; Wasserman K; Stanopoulos I
    Respirology; 2011 Apr; 16(3):451-8. PubMed ID: 21122030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oxygen on exercise-induced increase of pulmonary arterial pressure in idiopathic pulmonary fibrosis.
    Pouwels-Fry S; Pouwels S; Fournier C; Duchemin A; Tillie-Leblond I; Le Tourneau T; Wallaert B
    Sarcoidosis Vasc Diffuse Lung Dis; 2008 Dec; 25(2):133-9. PubMed ID: 19382532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and clinical characteristics of pulmonary hypertension in patients with idiopathic pulmonary fibrosis.
    Yan W; Peng LY; Ban CJ; Xu XF; Zhu M; Liu Y; Zhang S; Zhai ZG; Wang C; Dai HP
    Chin Med J (Engl); 2015 Apr; 128(7):896-901. PubMed ID: 25836609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right Ventricular Structure and Function in Idiopathic Pulmonary Fibrosis with or without Pulmonary Hypertension.
    D'Andrea A; Stanziola A; Di Palma E; Martino M; D'Alto M; Dellegrottaglie S; Cocchia R; Riegler L; Betancourt Cordido MV; Lanza M; Maglione M; Diana V; Calabrò R; Russo MG; Vannan M; Bossone E
    Echocardiography; 2016 Jan; 33(1):57-65. PubMed ID: 26096076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The strengths and weaknesses of non-invasive parameters obtained by echocardiography and cardiopulmonary exercise testing in comparison with the hemodynamic assessment by the right heart catheterization in patients with pulmonary hypertension.
    Ptaszyńska-Kopczyńska K; Krentowska A; Sawicka E; Skoneczny A; Jasiewicz M; Knapp M; Musiał WJ; Sobkowicz B; Kamiński KA
    Adv Med Sci; 2017 Mar; 62(1):39-44. PubMed ID: 28187374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echocardiography, 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosis.
    Modrykamien AM; Gudavalli R; McCarthy K; Parambil J
    Respir Care; 2010 May; 55(5):584-8. PubMed ID: 20420729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic Role of Ventilatory Inefficiency and Exercise Capacity in Idiopathic Pulmonary Fibrosis.
    Vainshelboim B; Oliveira J; Fox BD; Kramer MR
    Respir Care; 2016 Aug; 61(8):1100-9. PubMed ID: 27165419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary vascular limitation to exercise and survival in idiopathic pulmonary fibrosis.
    van der Plas MN; van Kan C; Blumenthal J; Jansen HM; Wells AU; Bresser P
    Respirology; 2014 Feb; 19(2):269-275. PubMed ID: 24251797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen uptake is more efficient in idiopathic pulmonary arterial hypertension than in chronic thromboembolic pulmonary hypertension.
    Shi X; Guo J; Gong S; Sapkota R; Yang W; Liu H; Xiang W; Wang L; Sun X; Liu J
    Respirology; 2016 Jan; 21(1):149-56. PubMed ID: 26390972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.
    Kimura M; Taniguchi H; Kondoh Y; Kimura T; Kataoka K; Nishiyama O; Aso H; Sakamoto K; Hasegawa Y
    Respiration; 2013; 85(6):456-63. PubMed ID: 23257350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary hypertension in idiopathic pulmonary fibrosis does not influence six-minute walk distance: results from a retrospective study.
    Harari S; Caminati A; Cassandro R; Conti S; Madotto F; Luisi F; Cesana G
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jan; 31(4):297-305. PubMed ID: 25591141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of end-tidal CO
    Higashi A; Dohi Y; Yamabe S; Kinoshita H; Sada Y; Kitagawa T; Hidaka T; Kurisu S; Yamamoto H; Yasunobu Y; Kihara Y
    Heart Vessels; 2017 Nov; 32(11):1350-1357. PubMed ID: 28560485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension in idiopathic pulmonary fibrosis: a review.
    Pitsiou G; Papakosta D; Bouros D
    Respiration; 2011; 82(3):294-304. PubMed ID: 21677422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of echocardiography in the identification of an excessive increase in pulmonary arterial pressure in patients with systemic sclerosis.
    Ciurzyński M; Bienias P; Irzyk K; Rymarczyk Z; Kostrubiec M; Szewczyk A; Glińska-Wielochowska M; Zyłkowska J; Kurzyna M; Pruszczyk P
    Kardiol Pol; 2011; 69(1):9-15. PubMed ID: 21267956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary hypertension in chronic lung diseases.
    Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension in advanced lung diseases: Echocardiography as an important part of patient evaluation for lung transplantation.
    Nowak J; Hudzik B; Jastrzȩbski D; Niedziela JT; Rozentryt P; Wojarski J; Ochman M; Karolak W; Żegleń S; Gierlotka M; Gąsior M
    Clin Respir J; 2018 Mar; 12(3):930-938. PubMed ID: 28052583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive screening for pulmonary hypertension in idiopathic pulmonary fibrosis.
    Alkukhun L; Wang XF; Ahmed MK; Baumgartner M; Budev MM; Dweik RA; Tonelli AR
    Respir Med; 2016 Aug; 117():65-72. PubMed ID: 27492515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron deposition and increased alveolar septal capillary density in nonfibrotic lung tissue are associated with pulmonary hypertension in idiopathic pulmonary fibrosis.
    Kim KH; Maldonado F; Ryu JH; Eiken PW; Hartman TE; Bartholmai BJ; Decker PA; Yi ES
    Respir Res; 2010 Apr; 11(1):37. PubMed ID: 20398288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducibility of cardiopulmonary exercise measurements in patients with pulmonary arterial hypertension.
    Hansen JE; Sun XG; Yasunobu Y; Garafano RP; Gates G; Barst RJ; Wasserman K
    Chest; 2004 Sep; 126(3):816-24. PubMed ID: 15364761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiopulmonary exercise test characteristics in patients with chronic obstructive pulmonary disease and associated pulmonary hypertension.
    Holverda S; Bogaard HJ; Groepenhoff H; Postmus PE; Boonstra A; Vonk-Noordegraaf A
    Respiration; 2008; 76(2):160-7. PubMed ID: 17960052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.